首页> 外文期刊>The biochemical journal >Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective
【24h】

Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective

机译:抑制线粒体钙非依赖性磷脂酶A2(iPLA2)可减轻线粒体磷脂损失并具有心脏保护作用

获取原文

摘要

pCalcium-independent phospholipase Asub2/sub (iPLAsub2/sub) is the predominant phospholipase Asub2/sub present in myocardium, and its pathophysiological role in acute myocardial infarction has been suggested by the rapid increase in membrane-associated iPLAsub2/sub activity during myocardial ischaemia and reperfusion (I/R). We therefore examined iPLAsub2/sub in mitochondrial fractions prepared from Langendorff-perfused adult rabbit hearts. Our studies indicate that iPLAsub2/subβ is present in rabbit heart mitochondrial inner membranes with no apparent translocation during ischaemia, I/R or preconditioning. Mitochondrion-associated iPLAsub2/sub was catalytically competent and exhibited 2-, 3- and 2.5-fold increases in measured iPLAsub2/sub activity following ischaemia, I/R and preconditioning, respectively, when compared with the activity of iPLAsub2/sub measured in mitochondria from control hearts. Mitochondrial phospholipids are essential for maintaining the ordered structure and function of the organelle. I/R resulted in a rapid overall decrease in phosphatidylcholine and phosphatidylethanolamine glycerophospholipid species, as determined by electrospray ionization MS, that was partially alleviated by pretreatment of hearts with the iPLAsub2/sub-specific inhibitor, bromoenol lactone (BEL). Pretreatment of I/R hearts with 10iμ/iM BEL significantly reduced the infarct size almost to that of continuously perfused hearts and was cardioprotective only when administered prior to ischaemia. Cardioprotection by BEL was reversed by the simultaneous perfusion of 100iμ/iM 5-hydroxydecanoate, implicating the mitochondrial KsubATP/sub channel in BEL-mediated protection from I/R. Preconditioning also significantly reduced the infarct size in response to I/R but protection was lost by concurrent perfusion of 10iμ/iM arachidonic acid. Taken together, these data strongly implicate mitochondria-associated iPLAsub2/sub in the signal transduction of myocardial I/R injury./p
机译:>非钙依赖性磷脂酶A 2 (iPLA 2 )是心肌中主要的磷脂酶A 2 ,在急性心肌梗死中其病理生理作用心肌缺血和再灌注(I / R)过程中与膜相关的iPLA 2 活性的快速增加提示了心肌梗塞。因此,我们检查了从Langendorff灌注的成年兔心脏制备的线粒体组分中的iPLA 2 。我们的研究表明,iPLA 2 β存在于兔心脏线粒体内膜中,在缺血,I / R或预处理期间没有明显的移位。线粒体相关的iPLA 2 具有催化能力,在缺血,I / R和预处理后,其iPLA 2 活性分别提高了2倍,3倍和2.5倍,与对照组心脏线粒体中iPLA 2 的活性进行比较。线粒体磷脂对于维持细胞器的有序结构和功能至关重要。通过电喷雾电离质谱分析,I / R导致磷脂酰胆碱和磷脂酰乙醇胺甘油磷脂种类的总体快速下降,其通过使用iPLA 2 特异性抑制剂溴烯醇内酯(BEL)预处理心脏而部分缓解)。用10μMBEL对I / R心脏进行预处理可将梗死面积显着减小至几乎与连续灌注的心脏相似,并且仅在缺血前给药才具有心脏保护作用。 BEL的心脏保护作用可通过同时灌注100μM5-羟基癸酸酯来逆转,这暗示线粒体K ATP 通道参与BEL介导的I / R保护。预处理还显着降低了对I / R的梗塞面积,但同时灌注10μM花生四烯酸失去了保护作用。综上所述,这些数据强烈暗示着线粒体相关的iPLA 2 参与了心肌I / R损伤的信号转导。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号